Highlights and Quick Summary
- EPS (Basic, from Continuous Ops) for the quarter ending December 31, 2022 was -0.13 (a 225.0% increase compared to previous quarter)
- Year-over-year quarterly EPS (Basic, from Continuous Ops) increased by 30.0%
- Annual EPS (Basic, from Continuous Ops) for 2022 was -0.4 (a -28.57% decrease from previous year)
- Annual EPS (Basic, from Continuous Ops) for 2021 was -0.56 (a -11.11% decrease from previous year)
- Annual EPS (Basic, from Continuous Ops) for 2020 was -0.63 (a -42.2% decrease from previous year)
- Twelve month EPS (Basic, from Continuous Ops) ending December 31, 2022 was -0.4 (a -6.98% decrease compared to previous quarter)
- Twelve month trailing EPS (Basic, from Continuous Ops) decreased by -27.27% year-over-year
Trailing EPS (Basic, from Continuous Ops) for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -0.4 | -0.43 | -0.52 | -0.55 |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Basic, from Continuous Ops) of Precigen, Inc.
Most recent EPS (Basic, from Continuous Ops)of PGEN including historical data for past 10 years.Interactive Chart of EPS (Basic, from Continuous Ops) of Precigen, Inc.
Precigen, Inc. EPS (Basic, from Continuous Ops) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -0.13 | -0.04 | -0.13 | -0.1 | -0.4 |
| 2021 | -0.16 | -0.13 | -0.16 | -0.11 | -0.56 |
| 2020 | -0.23 | -0.17 | -0.1 | -0.13 | -0.63 |
| 2019 | -0.22 | -0.32 | -0.21 | -0.34 | -1.09 |
| 2018 | -1.56 | -0.45 | -0.52 | -0.37 | -2.9 |
| 2017 | 0.19 | -0.34 | -0.16 | -0.27 | -0.59 |
| 2016 | -0.38 | -0.25 | -0.42 | -0.56 | -1.61 |
| 2015 | -0.31 | -0.35 | -0.38 | 0.24 | -0.79 |
| 2014 | 0.18 | -0.54 | -0.54 | 0.03 | -0.86 |
| 2013 | 6.3 | 0.28 | -1.15 | -6.42 | -1.0 |
| 2012 | -3.67 | -3.01 | – | – | -14.79 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology